None listed
Conditions
Interventions
Group RD:Ropivacaine + Dexamethasone
Sponsors
The First Affiliated Hospital of University of Science and Technology of China
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with elective thoracoscopic lobectomy; 2. Gender is not limited, aged 18 to 70 years; 3. BMI is in the range of 18.5-30kg/m^2, and ASA is graded I-III; 4. Voluntarily participate in this research and sign the preoperative informed consent; 5. The patient has the ability to accurately complete the pain assessment.
Exclusion criteria
Exclusion criteria: 1. History of previous thoracic surgery; 2. Coagulation disorders, etc.; 3. Liver and kidney insufficiency, cardiac insufficiency (New York Heart Association grades III-IV), pulmonary function damage (forced expiratory volume within 1s <50% predicted value); 4. Allergy to local anesthetics or opioids; 5. Preoperative history of chronic pain or continuous analgesia; 6. Whole body or puncture site infection; 7. Peripheral nervous system disease or nerve damage in the SAPB area; 8. Diabetes; 9. Other conditions that the investigator believes that the patient does not meet the conditions of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The sum of pressing numbers within 48h after surgery;The time to first patients-controlled bolus; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of additional analgesia;The occurrence of wound infection;The occurrence of nausea and vomiting;Visual analogue scale; | — |
Countries
China
Contacts
Public ContactWang Di
Outcome results
None listed